Huvepharma, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the acquisition of T-HEXX Animal Health, a division of Hydromer, Inc. The T-HEXX lines of products are based upon innovative hydrophilic polymer technologies for animal health, primarily in the dairy and equine markets.
T-HEXX Animal Health manufacturers and sells a broad range of products utilizing patented hydrophilic polymer technologies designed for mastitis management in dairy cattle, hoof care, and unique germicidal topical products for horses. They serve customers in the U.S. and internationally.
“The purchase of T-HEXX Animal Health supports Huvepharma’s vision for growth and development,” remarked Glen Wilkinson, President of Huvepharma U.S. “T-HEXX has created great products for the dairy and equine markets and we are thrilled to add these unique product lines to our portfolio.”
“Huvepharma will immediately assume marketing and sales of T-HEXX brands to our current customers while utilizing the sales and marketing strengths of AgriLabs. This timely purchase appropriately follows the recent announcement of a new dairy cattle vaccine – KLEBVax SRP,” added Wilkinson.